Filed Pursuant to Rule 424(b)(3)
Registration No. 333-275229
PROSPECTUS SUPPLEMENT
(to Prospectus dated November 7, 2023)

AlphaTON Capital Corp
481,581 Ordinary Shares underlying Warrants
This prospectus supplement is being
filed to update and supplement the information contained in the prospectus dated November 7, 2023 (the “Prospectus”), which
forms a part of our Registration Statement on Form F-1 (Registration No. 333-275229), as amended most recently by the post-effective amendment
filed on August 23, 2024, with the information contained in our current report on Form 6-K, furnished to the Securities and Exchange Commission
on October 22, 2025 (the “October 22, 2025 Form 6-K”). Accordingly, we have attached the October 22, 2025 Form 6-K to this
prospectus supplement.
This prospectus supplement updates
and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination
with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the
Prospectus, and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely
on the information in this prospectus supplement.
Our Ordinary
Shares are listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “ATON”. On October 21, 2025, the closing
sale price of our Ordinary Shares as reported on Nasdaq was $5.31.
_____________________________
Investing in the securities offered in the Prospectus involves
a high degree of risk. Before making any investment in these securities, you should consider carefully the risks and uncertainties in
the section entitled “Risk Factors” beginning on page 9 of the Prospectus, and in the other documents that are incorporated
by reference into the Prospectus.
Neither the Securities and Exchange Commission nor
any state or non-U.S. regulatory body has approved or disapproved of the securities offered in the Prospectus or passed upon the accuracy
or adequacy of the Prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.
_____________________________
The date of this prospectus supplement is October
22, 2025
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2025
Commission File Number: 001-40086
AlphaTON Capital Corp
(Translation of registrant's name into English)
Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British
Virgin Islands, VG1110
(Address of principal executive office)
| Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. |
| |
| Form 20-F [ X ] |
Form 40-F [ ] |
INCORPORATION BY REFERENCE
This report on Form 6-K (including any exhibits attached hereto) shall
be deemed to be incorporated by reference into the registration statements on Form S-8 (File Nos. 333-275842 and 333-289199) and Form
F-3 (File Nos. 333-286961 and 333-290827) of AlphaTON Capital Corp (including any prospectuses forming a part of each such registration
statement) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports
subsequently filed or furnished.
There were 6,349,197 ordinary shares of AlphaTON Capital Corp outstanding
as of October 20, 2025.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 22, 2025
ALPHATON CAPITAL CORP
| By: |
/s/ Brittany Kaiser |
|
| |
Brittany Kaiser |
| |
Chief Executive Officer |
| |
|